Columbia Technology Ventures
Rare Disease
Search text
Active Filters
Jerry Kokoshka
1 result
(0.04 seconds)
This technology is a monoclonal antibody which binds annexin for the inhibition of Funsobacterium nucleatum (Fn) invasion and proliferation to treat and prevent Fn related diseases including colorectal cancer and Familial Adenomatous Polyposis (FAP).